The influence of non-A, non-B (NANB) agent(s) on the aetiology of acute sporadic viral hepatitis and its possible transition to chronic hepatitis were studied. Acute sporadic NANB hepatitis was diagnosed in 134 (13.5%) of the 993 Greek adults who were admitted consecutively to the Western Attica Gen
Aetiology of acute sporadic non-A, non-B viral hepatitis in India
β Scribed by Dr.(Mrs) V. A. Arankalle; L. P. Chobe; J. Jha; M. S. Chadha; K. Banerjee; M. O. Favorov; T. Kalinina; H. Fields
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 491 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
NonβA, nonβB (NANB) hepatitis viruses are now classified as hepatitis E (enterically transmitted) and hepatitis C (parenterally transmitted). India experiences a large number of epidemics of the enteric disease every year. In addition, about 70% of the sporadic cases among adults are also due to NANB hepatitis. With the availability of an immunoblot assay for the detection of antiβHEVIgM and the polymerase chain reaction (PCR) for the detection of HCVβRNA, serum samples from epidemic and sporadic NANB patients were screened for these markers. We found that a large number of cases from the epidemics were HEV, though a few remained undiagnosed, while of the sporadic cases only a few could be diagnosed as HCV or HEV; a large proportion remained undiagnosed. Β© 1993 WileyβLiss, Inc.
π SIMILAR VOLUMES
could be attributed to hepatitis C infection. 5 Rarely, acute Patients presenting with clinical and laboratory feahepatitis E has been identified among U.S. or European patures consistent with a diagnosis of acute non-A, non-B tients with a history of recent travel to underdeveloped counhepatitis we
In a 4-year follow-up study, patients with acute sporadic non-A, non-B (NANB) hepatitis were evaluated to determine the etiology and natural history of the disease. Acute hepatitis C virus (HCV) was detected in 13 of 43 (30%) of patients, anti-hepatitis E virus (HEV) IgG in 5 (12%), and 25 (58%) wer
Markers for acute hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis non-A, non-B (HNANB) infections were examined in the sera of 94 patients presenting with acute hepatitis in Kenya. Hepatitis B virus was responsible for 70% of cases, HNANB for 18%, and HAV for only 12%. The use of an
A double-blind trial was carried out on 124 randomized patients with acute viral hepatitis, of whom 58 were treated with (+)-cyanidanol-3 in a dose of 3 g m per day and 66 with placebo. The treatment was given for 50 days. At 5-day intervals, SGPT, SGOT, and total serum bilirubin levels were tested.
Two chimpanzees with persistent non-A, non-B (NANB) hepatitis were superinfected with marmoset-passaged MS-1 HAV. Two control chimpanzees were also infected with marmoset-passaged HAV. Neither animal with persistent NANB hepatitis developed elevated alanine aminotransferase (ALT) activity, whereas b